Consolidated Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7344479

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
24,153,000,000 JPY
27,559,000,000 JPY
24,335,000,000 JPY
27,950,000,000 JPY
Depreciation
4,929,000,000 JPY
4,360,000,000 JPY
Impairment losses
59,000,000 JPY
69,000,000 JPY
Amortization of goodwill
1,128,000,000 JPY
998,000,000 JPY
Interest and dividend income
-763,000,000 JPY
-579,000,000 JPY
Interest expenses
29,000,000 JPY
18,000,000 JPY
Subtotal
25,986,000,000 JPY
39,363,000,000 JPY
Decrease (increase) in trade receivables
-3,781,000,000 JPY
8,296,000,000 JPY
Income taxes paid
-8,358,000,000 JPY
-8,003,000,000 JPY
Decrease (increase) in inventories
-3,175,000,000 JPY
-1,977,000,000 JPY
Net cash provided by (used in) operating activities
18,360,000,000 JPY
31,914,000,000 JPY
Increase (decrease) in trade payables
-1,390,000,000 JPY
1,240,000,000 JPY
Other, net
16,000,000 JPY
-431,000,000 JPY
Interest and dividends received
754,000,000 JPY
572,000,000 JPY
Interest paid
-22,000,000 JPY
-18,000,000 JPY
Cash flows from investing activities
Purchase of securities
-4,000,000,000 JPY
-2,000,000,000 JPY
Payments into time deposits
-45,132,000,000 JPY
-47,567,000,000 JPY
Proceeds from withdrawal of time deposits
50,216,000,000 JPY
45,996,000,000 JPY
Purchase of property, plant and equipment
-12,756,000,000 JPY
-14,747,000,000 JPY
Proceeds from sale of property, plant and equipment
5,000,000 JPY
3,000,000 JPY
Net cash provided by (used in) investing activities
-19,576,000,000 JPY
-14,312,000,000 JPY
Purchase of investment securities
-220,000,000 JPY
-19,000,000 JPY
Proceeds from sale of investment securities
531,000,000 JPY
45,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-11,176,000,000 JPY
JPY
Other, net
-231,000,000 JPY
-253,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-12,000,000,000 JPY
-14,056,000,000 JPY
Dividends paid
-7,223,000,000 JPY
-6,509,000,000 JPY
Net increase (decrease) in short-term borrowings
JPY
-1,000,000 JPY
Net cash provided by (used in) financing activities
-19,463,000,000 JPY
-20,759,000,000 JPY
Other, net
-239,000,000 JPY
-191,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
890,000,000 JPY
673,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-19,789,000,000 JPY
-2,484,000,000 JPY
Cash and cash equivalents
59,690,000,000 JPY
79,480,000,000 JPY
81,987,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.